Pfizer submits promising data to FDA from vaccine trial with kids ages 5-11

Pfizer and BioNTech have submitted data to the U.S. Food and Drug Administration on Tuesday from a trial on the effects of the COVID-19 vaccine on children between 5-12 years old.